Clinical Identification and Therapeutic Approaches to Paradoxical Adipose Hyperplasia: A Systematic Review of Post-Cryolipolysis Complications

Background: Cryolipolysis has emerged as a popular non-invasive body contouring procedure for localized fat reduction. While generally considered safe, paradoxical adipose hyperplasia (PAH) represents a rare but significant adverse effect characterized by paradoxical growth of adipose tissue in treated areas. Purpose: This review aims to systematically evaluate the current literature regarding the clinical identification, incidence, pathophysiology, risk factors, and therapeutic management approaches for PAH following cryolipolysis procedures. Materials and Methods: A comprehensive search of electronic databases including PubMed, Scopus, MEDLINE, and Embase was conducted for articles published between January 2010 and December 2023. Keywords included “cryolipolysis,” “paradoxical adipose hyperplasia,” “CoolSculpting complications,” and “post-cryolipolysis adverse effects.” Results: Nineteen studies met inclusion criteria, comprising documented cases of PAH. The estimated incidence ranges from 0.0051% to 0.72%, with higher rates observed in studies employing active surveillance methods. Clinical identification features include delayed-onset, sharply demarcated, firm enlargement of the treated area. Male sex and treatment of abdominal areas were identified as potential risk factors. Management approaches include observation, massage therapy, energy-based treatments, and surgical intervention, with liposuction demonstrating the highest efficacy rates. Conclusions: PAH remains an uncommon but distressing complication of cryolipolysis with potentially significant psychosocial impact on affected patients. This review establishes clinical identification criteria and provides evidence-based management recommendations for practitioners.